Value of Plasmatic Membrane Attack Complex as a Marker of Severity in Acute Kidney Injury

The aim of this study was to determine if complement pathway is activated in AKI; for this purpose, we measured, through ELISA sandwich, the terminal lytic fraction of the complement system, called membrane attack complex (C5b-C9), in AKI patients compared with patients with similar clinical conditi...

Full description

Bibliographic Details
Main Authors: Rodríguez, Eva, Riera, Marta, Barrios, Clara, Pascual, Julio
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055497/
id pubmed-4055497
recordtype oai_dc
spelling pubmed-40554972014-06-25 Value of Plasmatic Membrane Attack Complex as a Marker of Severity in Acute Kidney Injury Rodríguez, Eva Riera, Marta Barrios, Clara Pascual, Julio Research Article The aim of this study was to determine if complement pathway is activated in AKI; for this purpose, we measured, through ELISA sandwich, the terminal lytic fraction of the complement system, called membrane attack complex (C5b-C9), in AKI patients compared with patients with similar clinical conditions but normal renal function. Our data showed that complement system is activated in AKI. Plasmatic MAC concentrations were significantly higher in AKI patients than in those with normal renal function; this difference is maintained independently of the AKI etiology and is proportional to the severity of AKI, measured by ADQI classification. In addition, we found that plasmatic MAC concentrations were significantly higher in patients who did not recover renal function at time of hospitalization discharge, in patients who died during the acute process, and in patients who need renal replacement therapy during hospitalization, but in this last group, the differences did not reach statistical significance. In conclusion, plasmatic MAC concentration seems valuable as a marker of AKI severity. Hindawi Publishing Corporation 2014 2014-05-25 /pmc/articles/PMC4055497/ /pubmed/24967359 http://dx.doi.org/10.1155/2014/361065 Text en Copyright © 2014 Eva Rodríguez et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Rodríguez, Eva
Riera, Marta
Barrios, Clara
Pascual, Julio
spellingShingle Rodríguez, Eva
Riera, Marta
Barrios, Clara
Pascual, Julio
Value of Plasmatic Membrane Attack Complex as a Marker of Severity in Acute Kidney Injury
author_facet Rodríguez, Eva
Riera, Marta
Barrios, Clara
Pascual, Julio
author_sort Rodríguez, Eva
title Value of Plasmatic Membrane Attack Complex as a Marker of Severity in Acute Kidney Injury
title_short Value of Plasmatic Membrane Attack Complex as a Marker of Severity in Acute Kidney Injury
title_full Value of Plasmatic Membrane Attack Complex as a Marker of Severity in Acute Kidney Injury
title_fullStr Value of Plasmatic Membrane Attack Complex as a Marker of Severity in Acute Kidney Injury
title_full_unstemmed Value of Plasmatic Membrane Attack Complex as a Marker of Severity in Acute Kidney Injury
title_sort value of plasmatic membrane attack complex as a marker of severity in acute kidney injury
description The aim of this study was to determine if complement pathway is activated in AKI; for this purpose, we measured, through ELISA sandwich, the terminal lytic fraction of the complement system, called membrane attack complex (C5b-C9), in AKI patients compared with patients with similar clinical conditions but normal renal function. Our data showed that complement system is activated in AKI. Plasmatic MAC concentrations were significantly higher in AKI patients than in those with normal renal function; this difference is maintained independently of the AKI etiology and is proportional to the severity of AKI, measured by ADQI classification. In addition, we found that plasmatic MAC concentrations were significantly higher in patients who did not recover renal function at time of hospitalization discharge, in patients who died during the acute process, and in patients who need renal replacement therapy during hospitalization, but in this last group, the differences did not reach statistical significance. In conclusion, plasmatic MAC concentration seems valuable as a marker of AKI severity.
publisher Hindawi Publishing Corporation
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055497/
_version_ 1612100443379335168